Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

About Max-Planck-Gesellschaft

The research institutes of the Max Planck Society perform basic research in the interest of the general public in the natural sciences, life sciences, social sciences, and the humanities. In particular, the Max Planck Society takes up new and innovative research areas that German universities are not in a position to accommodate or deal with adequately. These interdisciplinary research areas often do not fit into the university organization, or they require more funds for personnel and equipment than those available at universities. The variety of topics in the natural sciences and the humanities at Max Planck Institutes complement the work done at universities and other research facilities in important research fields. In certain areas, the institutes occupy key positions, while other institutes complement ongoing research. Moreover, some institutes perform service functions for research performed at universities by providing equipment and facilities to a wide range of scientists, such as telescopes, large-scale equipment, specialized libraries, and documentary resources.

Facts about Max-Planck-Gesellschaft
  • Industry : Other

News about Max-Planck-Gesellschaft

Here you will find Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

Last viewed contents

Novozymes Biopharma Signs License Agreement with GE Healthcare to Produce and Sell Protein A

Biotech has Positive Year Despite Weak Fourth Quarter Performance - Burrill looks back at 2007

Nanoscale ruler reveals organization of the cell membrane - Freiburg biologists measure distances and the arrangement of membrane molecules in nanometer range

Nanoscale ruler reveals organization of the cell membrane - Freiburg biologists measure distances and the arrangement of membrane molecules in nanometer range

Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018

Tripos to Build One of the Leading Informatics-Driven Drug Discovery Laboratories in Europe - - State-of-the-Art Chemical Synthesis Facilities to be Built in Cornwall, England -

5 Leading Multinationals Announce R&D Projects for Ireland - Bristol-Myers Squibb Company, Pfizer Inc., Genzyme Corporation, Xilinx Inc. Citigroup are investing a total of EUR 53.25 million

Pesticides and other common chemical pollutants are toxic to our ‘good’ gut bacteria

Pesticides and other common chemical pollutants are toxic to our ‘good’ gut bacteria

Munich-based lab automation startup raised €2.77M - AI-driven biotech research: Connected labs for faster scientific progress

Munich-based lab automation startup raised €2.77M - AI-driven biotech research: Connected labs for faster scientific progress

How machine learning, data integration and AI contribute to better strategies in the fight against pathogens - Researchers develop a new machine learning approach

How machine learning, data integration and AI contribute to better strategies in the fight against pathogens - Researchers develop a new machine learning approach

Gene_therapy

Adapting the Power of Density Gradient Separations for Gene Therapy Analytics - DGE-AUC (Density Gradient Equilibrium AUC) highly simplified analytical method

Adapting the Power of Density Gradient Separations for Gene Therapy Analytics - DGE-AUC (Density Gradient Equilibrium AUC) highly simplified analytical method

Fast and Reproducible AAV Quantification - Fast, Direct, and Label-free Quantitation of AAV Capsids in Bioprocess Control

Fast and Reproducible AAV Quantification - Fast, Direct, and Label-free Quantitation of AAV Capsids in Bioprocess Control